Terms: = Kidney tumors AND SFPQ, PSF, 6421, ENSG00000116560, P23246
39 results:
1. Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis.
Prakasam G; Mishra A; Christie A; Miyata J; Carrillo D; Tcheuyap VT; Ye H; Do QN; Wang Y; Reig Torras O; Butti R; Zhong H; Gagan J; Jones KB; Carroll TJ; Modrusan Z; Durinck S; Requena-Komuro MC; Williams NS; Pedrosa I; Wang T; Rakheja D; Kapur P; Brugarolas J
J Clin Invest; 2024 Feb; 134(7):. PubMed ID: 38386415
[TBL] [Abstract] [Full Text] [Related]
2. PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma.
Zhao M; Huang Y; Yin X; Xu J; Sun Y; Wang J
Histopathology; 2024 Feb; 84(3):482-491. PubMed ID: 37936565
[TBL] [Abstract] [Full Text] [Related]
3. Dual role of G-quadruplex in translocation renal cell carcinoma: Exploring plausible Cancer therapeutic innovation.
Neha ; Das P; Verma SP
Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129719. PubMed ID: 32882363
[TBL] [Abstract] [Full Text] [Related]
4. [Xp11 neoplasma with melanocytic differentiation: a clinicopathological analysis].
Wang XT; Zhang RS; Li R; Ye SB; Wang X; Xia QY; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2019 Dec; 48(12):945-950. PubMed ID: 31818068
[No Abstract] [Full Text] [Related]
5. Xp11.2 translocation renal cell carcinoma with sfpq/psf-TFE3 fusion gene: A case report with unusual histopathologic findings.
Ishikawa N; Nagase M; Takami S; Nagano N; Araki A; Iwahashi T; Yamauchi N; Yamasaki T; Shiina H; Maruyama R
Pathol Res Pract; 2019 Sep; 215(9):152479. PubMed ID: 31153695
[TBL] [Abstract] [Full Text] [Related]
6. A novel human lncRNA SANT1
Gao Z; Chen M; Tian X; Chen L; Chen L; Zheng X; Wang H; Chen J; Zhao A; Yao Q; Zhu Q; Jin S; Hu H; Zeng S; Yu L
RNA Biol; 2019 Jul; 16(7):940-949. PubMed ID: 30951404
[No Abstract] [Full Text] [Related]
7. Two-dimensional shear wave elastography of the perirenal fat: Can sticky fat be predicted?
Çamlıdağ İ; Öner S; Özden E
J Clin Ultrasound; 2019 May; 47(4):201-205. PubMed ID: 30560576
[TBL] [Abstract] [Full Text] [Related]
8. Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma.
Damayanti NP; Budka JA; Khella HWZ; Ferris MW; Ku SY; Kauffman E; Wood AC; Ahmed K; Chintala VN; Adelaiye-Ogala R; Elbanna M; Orillion A; Chintala S; Kao C; Linehan WM; Yousef GM; Hollenhorst PC; Pili R
Clin Cancer Res; 2018 Dec; 24(23):5977-5989. PubMed ID: 30061365
[TBL] [Abstract] [Full Text] [Related]
9. RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations.
Wang XT; Xia QY; Ye SB; Wang X; Li R; Fang R; Shi SS; Zhang RS; Tan X; Chen JY; Sun K; Teng XD; Ma HH; Lu ZF; Zhou XJ; Rao Q
Mod Pathol; 2018 Sep; 31(9):1346-1360. PubMed ID: 29713041
[TBL] [Abstract] [Full Text] [Related]
10. Melanotic Translocation Renal Cell Carcinoma With a Novel ARID1B-TFE3 Gene Fusion.
Antic T; Taxy JB; Alikhan M; Segal J
Am J Surg Pathol; 2017 Nov; 41(11):1576-1580. PubMed ID: 28877054
[TBL] [Abstract] [Full Text] [Related]
11. Combination of immunohistochemistry, FISH and RT-PCR shows high incidence of Xp11 translocation RCC: comparison of three different diagnostic methods.
Lee HJ; Shin DH; Noh GY; Kim YK; Kim A; Shin N; Lee JH; Choi KU; Kim JY; Lee CH; Sol MY; Rha SH; Park SW
Oncotarget; 2017 May; 8(19):30756-30765. PubMed ID: 28415646
[TBL] [Abstract] [Full Text] [Related]
12. MicroRNA expression profiling of Xp11 renal cell carcinoma.
Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
[TBL] [Abstract] [Full Text] [Related]
13. sfpq/psf-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between sfpq-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion.
Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q
Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422
[TBL] [Abstract] [Full Text] [Related]
14. Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas.
Classe M; Malouf GG; Su X; Yao H; Thompson EJ; Doss DJ; Grégoire V; Lenobin J; Fantoni JC; Sudour-Bonnange H; Khayat D; Aubert S; Tannir NM; Leroy X
Histopathology; 2017 Jun; 70(7):1089-1097. PubMed ID: 28106924
[TBL] [Abstract] [Full Text] [Related]
15. Study of Splicing Factor, Proline- and Glutamine-rich by Proteomic Techniques in Human Malignant and Nonmalignant Cell Lines.
Pashintseva NV; Shishkin SS; Lisitskaya KV; Kovalev LI; Kovaleva MA; Eryomina LS; Kamenikhina IA; Novikova LA; Sadykhov EG
Protein Pept Lett; 2016; 23(11):958-966. PubMed ID: 27633854
[TBL] [Abstract] [Full Text] [Related]
16. Identification by FFPE RNA-Seq of a new recurrent inversion leading to RBM10-TFE3 fusion in renal cell carcinoma with subtle TFE3 break-apart FISH pattern.
Just PA; Letourneur F; Pouliquen C; Dome F; Audebourg A; Biquet P; Vidaud M; Terris B; Sibony M; Pasmant E
Genes Chromosomes Cancer; 2016 Jun; 55(6):541-8. PubMed ID: 26998913
[TBL] [Abstract] [Full Text] [Related]
17. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.
Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
[TBL] [Abstract] [Full Text] [Related]
18. Expression and protease activity of mouse legumain are regulated by the oncogene/transcription co-activator, DJ-1 through p53 and cleavage of annexin A2 is increased in DJ-1-knockout cells.
Yamane T; Yamamoto Y; Nakano Y; Nakagaki T; Ohkubo I; Ariga H
Biochem Biophys Res Commun; 2015 Nov; 467(3):472-7. PubMed ID: 26462467
[TBL] [Abstract] [Full Text] [Related]
19. psf/sfpq is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
[TBL] [Abstract] [Full Text] [Related]
20. Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications.
Agaram NP; Sung YS; Zhang L; Chen CL; Chen HW; Singer S; Dickson MA; Berger MF; Antonescu CR
Am J Surg Pathol; 2015 Jun; 39(6):813-25. PubMed ID: 25651471
[TBL] [Abstract] [Full Text] [Related]
[Next]
